News
Epigral consolidated net profit declines 37.00% in the September 2025 quarter
10-Nov-2025 | 16:17
Sales decline 6.18% to Rs 587.36 crore
Net profit of Epigral declined 37.00% to Rs 51.22 crore in the quarter ended September 2025 as against Rs 81.30 crore during the previous quarter ended September 2024. Sales declined 6.18% to Rs 587.36 crore in the quarter ended September 2025 as against Rs 626.06 crore during the previous quarter ended September 2024.
| Particulars | Quarter Ended | ||
| Sep. 2025 | Sep. 2024 | % Var. | |
| Sales | 587.36 | 626.06 | -6 |
| OPM % | 22.48 | 28.50 | - |
| PBDT | 111.96 | 157.43 | -29 |
| PBT | 69.65 | 125.18 | -44 |
| NP | 51.22 | 81.30 | -37 |
Powered by Capital Market - Live News